Tags

Type your tag names separated by a space and hit enter

Meningococcal disease and prevention at the Hajj.
Travel Med Infect Dis. 2009 Jul; 7(4):219-25.TM

Abstract

The Islamic Hajj pilgrimage to Mecca, Kingdom of Saudi Arabia (KSA) has historically been associated with outbreaks of Neisseria meningitidis serogroup A. The main means of prevention against meningococcal disease was the bivalent serogroup A/C polysaccharide vaccine. During the Hajj pilgrimages of 2000 and 2001, there was an epidemiological shift from serogroup A disease to serogroup W135 disease together with an increase in incidence in younger age groups. This prompted the Ministry of Health to introduce quadrivalent ACYW135 polysaccharide vaccines. These interventions have quelled meningococcal disease since 2002. Trials on meningococcal quadrivalent conjugate vaccines are now underway in the KSA.

Links

Publisher Full Text
Aggregator Full Text

Authors

Borrow R
No affiliation info available

MeSH

AdolescentAnti-Bacterial AgentsChildChild, PreschoolDisease OutbreaksHumansInfantIslamMeningococcal InfectionsMeningococcal VaccinesNeisseria meningitidisRisk FactorsSaudi ArabiaTravel

Pub Type(s)

Editorial

Language

eng

PubMed ID

19717104

Citation

Borrow, Ray. "Meningococcal Disease and Prevention at the Hajj." Travel Medicine and Infectious Disease, vol. 7, no. 4, 2009, pp. 219-25.
Borrow R. Meningococcal disease and prevention at the Hajj. Travel Med Infect Dis. 2009;7(4):219-25.
Borrow, R. (2009). Meningococcal disease and prevention at the Hajj. Travel Medicine and Infectious Disease, 7(4), 219-25. https://doi.org/10.1016/j.tmaid.2009.05.003
Borrow R. Meningococcal Disease and Prevention at the Hajj. Travel Med Infect Dis. 2009;7(4):219-25. PubMed PMID: 19717104.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Meningococcal disease and prevention at the Hajj. A1 - Borrow,Ray, Y1 - 2009/06/24/ PY - 2009/04/30/received PY - 2009/05/05/accepted PY - 2009/9/1/entrez PY - 2009/9/1/pubmed PY - 2009/12/23/medline SP - 219 EP - 25 JF - Travel medicine and infectious disease JO - Travel Med Infect Dis VL - 7 IS - 4 N2 - The Islamic Hajj pilgrimage to Mecca, Kingdom of Saudi Arabia (KSA) has historically been associated with outbreaks of Neisseria meningitidis serogroup A. The main means of prevention against meningococcal disease was the bivalent serogroup A/C polysaccharide vaccine. During the Hajj pilgrimages of 2000 and 2001, there was an epidemiological shift from serogroup A disease to serogroup W135 disease together with an increase in incidence in younger age groups. This prompted the Ministry of Health to introduce quadrivalent ACYW135 polysaccharide vaccines. These interventions have quelled meningococcal disease since 2002. Trials on meningococcal quadrivalent conjugate vaccines are now underway in the KSA. SN - 1873-0442 UR - https://www.unboundmedicine.com/medline/citation/19717104/Meningococcal_disease_and_prevention_at_the_Hajj_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1477-8939(09)00083-0 DB - PRIME DP - Unbound Medicine ER -